Treatment of the Fibromyalgia Syndrome

REFERENCES

• McCain G A. A clinical overview of the fibromyalgia syndrome. Proceedings of the Third International Conference on Fibromyalgia and Myofascial Pain-Myopain 95. J Musculoske Pain 1996; 4(1/2)9–34
   Google Scholar
• Carette S, McCain G A, Bell D A, Fam A G. Evaluation of amitriptyline in primary fibrositis. Arthritis Rheum 1986; 29: 655–659
   PubMed Web of Science ®Google Scholar
• Carette S, McCain G A, Bell D A, Fam A G. Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis Rheum 1986; 29: 655–659
   PubMed Web of Science ®Google Scholar
• Goldenberg D L, Felson D T, Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986; 29: 1371–1377
   PubMed Web of Science ®Google Scholar
• Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B. Clinical usefulness of amitriptyline in fibromyalgia: The results of 23 N-of-1 randomized controlled trials. J Rheumatol 1991; 18: 447–451
   PubMed Web of Science ®Google Scholar
• Scudds R A, McCain G A, Rollman G B, Harth M. Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol 1989; 16(suppl 19)113–119
   PubMedGoogle Scholar
• Reynolds W J, Moldofsky H, Saskin P, Lue F A. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol 1991; 18: 452–454
   PubMed Web of Science ®Google Scholar
• Bennett R M, Gatter R A, Campbell S M, Andrews R P, Clark S R, Scarlo J A. A comparison of cyclobenzaprine and placebo in the management of fibrositis. Arthritis Rheum 1988; 31(12)1535–1542
   PubMed Web of Science ®Google Scholar
• Quimby L G, Gratwick G M, Whitney C A, Block S R. A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol 1989; 16(Suppl 19)140–143
   Google Scholar
• Santandrea S, Montrone F, Sarzi-Puttini P, Boccassini L, Caruso I. A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome. Journal of International Research 1993; 21: 74–80
   Google Scholar
• Hamaty D, Valentine J L, Howard R, Howard C W, Wakefield V, Patten M S. The plasma endorphin prostaglandin and catecholamine profile in patients with fibrositis treated with cyclobenzaprine and placebo. J Rheumatol 1989; 16: S164–S168
   PubMed Web of Science ®Google Scholar
• Stratz T, Menne T, Benn H P. Blocking of S2 receptors: A new treatment principle in generalized tendo myopathy (fibromyalgia). Ziets Fur Rheumatol 1991; 50: 21–22
   PubMedGoogle Scholar
• Finestone D H. Fluoxetine and fibromyalgia. JAMA 1990; 264(22)2869–2870
   PubMedGoogle Scholar
• Geller S A. Treatment of fibrositis with fluoxetine hydrochloride (prozac). Am J Med 1989; 87: 594–595
   PubMed Web of Science ®Google Scholar
• Cortet B, Houvenagel E, Forzy G. Evaluation of the effectiveness of serotonin (fluoxetine hydrochloride) treatment: Open study in fibromyalgia. Revue Du Rheum Mal Osteo-Articulaires 1992; 59: 497–500
   PubMedGoogle Scholar
• Goldenberg D, Mayskiyy M, Mossey C, Ruthazer R, Schmid C. A randomized, double-blind crossover trial of fluoxetine an amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39: 1852–1859
   PubMed Web of Science ®Google Scholar
• Dwight M M, Arnold L M, O'Brien H, Metzger R, Morris-Park E, Keck P E, Jr. An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics 1998; 39: 14–17
   PubMed Web of Science ®Google Scholar
• Jung A C, Staiger T, Sullivan M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J Gen Intern Med 1997; 12: 384–389
   PubMed Web of Science ®Google Scholar
• Russell I J, Fletcher E M, Michalek J E, McBroom P C, Hester G G. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: A double-blind, placebo-controlled study. Arthritis Rheum 1991; 34: 552–560
   PubMed Web of Science ®Google Scholar
• Quijada-Carrera J, Valenzuela-Castano A, Provendano-Gomez J, Fernandez-Rodruigez A, Hernanz-Mediano W, Gutierrez-Rubio A, de la Iglesia-Salgado J L, Garcia-Lopez A. Comparison of tenoxicam and bromazepam in the treatment of fibromyalgia: A randomized, double-blind, placebo controlled trial. Pain 1996; 65: 221–225
   PubMed Web of Science ®Google Scholar
• Hrycaj P, Stratz T, Mennet P, Muller W. Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome -a preliminary study. J Rhematol 1996; 23: 1418–1423
   PubMed Web of Science ®Google Scholar
• Samborski W, Stratz T, Lacki J K, Klama K, Mennet P, Muller W. The 5-HT3 blockers in the treatment of the primary fibromyalgia syndrome: A 10 day open study with Tropisetron at a low dose. Mater Med Pol 1996; 28: 17–19
   PubMedGoogle Scholar
• Moldofsky H, Lue F A, Mously C, Roth-Schechter B, Reynolds W J. The effect of zolpidem in patients with fibromyalgia: A dose ranging, double blind, placebo controlled, modified crossover study. J Rheumatol 1996; 23: 529–533
   PubMed Web of Science ®Google Scholar
• Sorensen J, Bengtsson A, Ahlner J, Henriksson K G, Ekselius L, Bengtsson M. Fibromyalgia -are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 1997; 24: 1615–1621
   PubMed Web of Science ®Google Scholar
• Bennett R M, TPS-FM Study Group. A blinded, placebo-controlled evaluation of tramadol in the management of fibromyalgia pain. J Musculoske Pain 1998; 6(suppl 2), 146, (Abstract)
   Google Scholar
• Russell I J, the TPS-FM Study Group. Efficacy of Ultram (tramadol hcl) treatment of fibromyalgia syndrome (FMS): Secondary outcomes report. J Musculoske Pain 1998; 6(suppl 2), 147, (Abstract)
   Google Scholar
• Bennett R M, Clark S R, Campbell S M, Burckhardt C S. Low levels of somatomedin C in patients with the fibromyalgia syndrome. Arthritis Rheum 1992; 35: 1113–1116
   PubMed Web of Science ®Google Scholar
• Bagge E, Bengtsson B A, Carlsson L, Carlsson J. Low growth hormone secretion in patients with fibromyalgia-a preliminary report on 10 patients and 10 controls. J Rheumatol 1998; 25: 145–148
   PubMed Web of Science ®Google Scholar
• Bennett R M, Clark S C, Walczyk J. A randomized, double-blind, placebo controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 1998; 104: 227–231
   PubMed Web of Science ®Google Scholar
• Bengtsson A, Bengtsson M. Regional sympathetic blockade in primary fibromyalgia. Pain 1988; 33: 161–167, (Abstract)
   PubMed Web of Science ®Google Scholar
• Bengtsson M, Bengtsson A, Jorfeldt L. Diagnostic epidural blockade in primary fibromyalgia at rest and during exercise. Pain 1989; 39: 171–180
   PubMed Web of Science ®Google Scholar
• Wysenbeek A J, Nor F, Lurie T, Weinburger A. Imipramine for the treatment of fibrositis: A therapeutic trial. Ann Rheum Dis 1985; 44(11)752–753
   PubMedGoogle Scholar
• Bibolotti E, Borghi C, Paculli E. The management of fibrositis: A double blind comparison of maprotiline, chlorimipramine, and placebo. Clin Trials J 1986; 23: 269–280
   Google Scholar
• Moldofsky H, Warsh J J. Plasma tryptophan and musculoskeletal pain in nonarticular rheumatism. Pain 1978; 5: 65–71
   PubMed Web of Science ®Google Scholar
• Bessette L, Carette S, Fossel A H, Lew R A. A placebo controlled crossover trial of subcutaneous salmon calcitonin in the treatment of patients with fibromyalgia. Scand J Rheumatol 1998; 27: 112–116
   PubMed Web of Science ®Google Scholar
• Clark S R, Tindall E A, Bennett R A. A double-blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol 1985; 12: 980–983
   PubMed Web of Science ®Google Scholar
• Volkmann H, Norregaard J, Jacobsen S, Danneskiold-Samsöe B, Knoke G, Nehrdich D. Double-blind, placebo controlled cross-over study of intravenous S-adenosyl-methionine in patients with fibromyalgia. Scand J Rhematol 1997; 26: 206–211
   Google Scholar
• Janzen V, Scudds R A. Sphenopalatine blocks in the treatment of pain in fibromyalgia and myofascial pain. Laryngoscope 1997; 107: 1420–1422
   PubMed Web of Science ®Google Scholar
• Bennett R M, Clark S R, Goldberg L, Nelson D, Bonafide R P, Porter J, Specht D. Aerobic fitness in the fibrositis syndrome: A controlled study of respiratory gas exchange and 133 xenon clearance from exercise in muscle. Arthritis Rheum 1989; 32(4)454–460
   PubMedGoogle Scholar
• McCain G A. Non-medicinal treatments in fibromyalgia. Rheum Dis Clin N Am 1989; 15(1)73–90
   PubMed Web of Science ®Google Scholar
• McCain G A, Bell D A, Mai F, Halliday P D. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of the primary fibromyalgia syndrome. Arthritis Rheum 1988; 31(9)1135–1141
   PubMed Web of Science ®Google Scholar
• McCain G A, Bell D A, Mai F M, Halliday P D. A controlled study of the effects of a supervised cardiovascular fitness program on the manifestations of the primary fibromyalgia syndrome. A&R Primary Care Review 1990; 2(4)1–15
   Google Scholar
• McCain G A. Role of physical fitness training in the fibrositis/fibromyalgia syndrome. Am J Med 1986; 81(suppl 3A)73–77
   PubMed Web of Science ®Google Scholar
• Burckhardt C S, Mannerkorpi K, Hedenberg L, Bjelle A. A randomized controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 1994; 21: 714–720
   PubMed Web of Science ®Google Scholar
• Martin L, Edworthy S M, MacIntosh B. Is exercise helpful in treatment of fibromyalgia?. Arthritis & Rheumatism 1993; 36(suppl)S251
   Google Scholar
• Mengshoel A M, Aomnaes H B, Forre O. The effects of 20 weeks of physical fitness in females with fibromyalgia. Clin Exp Rheumatol 1992; 10: 345–349
   PubMed Web of Science ®Google Scholar
• Nichols D S, Glenn T M. Effects of aeorbic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy 1994; 74(4)327–332
   PubMed Web of Science ®Google Scholar
• Martin L, Nutting A, MacIntosh B R, Edworthy S M, Butterwick D. An exercise program in the treatment of fibromyalgia. J Rheumatol 1996; 23: 1050–1053
   PubMed Web of Science ®Google Scholar
• Wigers S H, Stiles T C, Vogel P A. Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scand J Rheumatol 1996; 25: 77–86
   PubMed Web of Science ®Google Scholar
• Furaccioli G, Chirelli L, Scita F, Nolli M, Mozzani M, Fontana S, Scorsonelli M, Trident A, DeRiso C. EMG-biofeedback training in fibromyalgia syndrome. J Rheumatol 1987; 14: 820–825
   PubMed Web of Science ®Google Scholar
• Deluze C, Bosia L, Zirbs A, Chantraine A, Vischer T L. Electroacupuncture in fibromyalgia: Results of a controlled trial. Br Med J 1992; 305: 1249–1252
   PubMed Web of Science ®Google Scholar
• Waylonis G. Subcutaneous electrical stimulation (acupuncture) in the clinical practice of physical medicine. Arch Phys Med Rehabil 1976; 57: 161–165
   PubMed Web of Science ®Google Scholar
• Waylonis G. Long term followup on patients with fibrositis treated with acupuncture. Ohio State Medical Journal 1977; 73: 299–302
   PubMedGoogle Scholar
• Lautenschager J, Schnorrenberger C C, Muller W. Akupnktur bei generalisierter tendomyopathie (fibromyalgie-syndrom). Dtsch Zschr Akup 1989; 6: 122–128
   Google Scholar
• Hannen H CM, Hoenderdos H TW, Van Romunde L KJ, Hop W CJ, Mallee C, Terwiel J P, Hekster B. Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. J Rheumatol 1991; 18: 72–75
   PubMed Web of Science ®Google Scholar
• Nielson W R, Walker C, McCain G A. Cognitive behavioural treatment of fibromyalgia syndrome: Preliminary findings. J Rheumatol 1991, (in press)
   Google Scholar
• White K P, Nielson W R. Cognitive behavioral treatment of fibromyalgia syndrome: A followup assessment. J Rheumatol 1995; 22: 717–721
   PubMed Web of Science ®Google Scholar
• Kaplan K H, Goldenberg D L, Galvin-Nadeau M. The impact of a meditation-based stress reduction program on fibromyalgia. General Hospital Psychiatry 1993; 15: 284–289
   PubMed Web of Science ®Google Scholar
• Bennett R M, Burckhardt C S, Clark S R, O'Reilly C A, Wiens A N. Group treatment of fibromyalgia: A 6 month outpatient program. J Rheumatol 1996; 23: 521–528
   PubMed Web of Science ®Google Scholar
• Molina E, Cecchettin M, Fontana S. Failure of EMG-BF after sham BF training in fibromyalgia. Fed Proc 1987; 46: 13–57
   Google Scholar
• Bradley L A. Cognitive behavioural therapy for fibromyalgia. J Rheumatol 1989; 16(suppl)131–136
   Google Scholar
• Gossens M E, Rutten van Molken M P, Leidl R M, Bos S G, Vlaeyen J W, Teeken-Gruben N J. Cognitive-educational treatment of fibromyalgia: A randomized clinical trial. II. Economic evaluation. J Rheumatol 1996; 23: 1246–1254
   PubMedGoogle Scholar
• Vlaeyen J W, Teeken-Gruben N J, Gossens M E, Rutten van Molken M P, Pelt R A, van Eek H, Heuts P H. Cognitive-educational treatment of fibromyalgia: A randomized clinical trial. I. Clinical effects. J Rhematol 1996; 23: 1237–1245
   PubMed Web of Science ®Google Scholar
• Nicassio P M, Radojevic V, Weisman M H, Schuman C, Kim J, Schoenfeld-Smith K, Krall T. A comparison of behavioral and educational intervention for fibromyalgia. J Rheumatol 1997; 24: 2000–2007
   PubMed Web of Science ®Google Scholar